Degrees: BS: Massachusetts Institute of Technology 1981 Electrical Engineering MS: Massachusetts Institute of Technology 1983 Electrical Engineering PhD: Massachusetts Institute of Technology 1987 Electrical Engineering MD: Harvard 1987 Medicine Professional Appointments: 1987-1988 Intern in Medicine, Brigham and Women's Hospital 1988-1990 Resident in Medicine, Brigham and Women's Hospital 1988-1990 Research Scientist, Harvard M.I.T. Division of H.S.T. 1990-1993 Fellow in Cardiology, Johns Hopkins University 1993-1998 Assistant Professor of Medicine, Johns Hopkins University 1996- Co-Director of Cardiac Electrophysiology, Johns Hopkins Hospital 1998-2005 Associate Professor of Medicine, Johns Hopkins University 2002-2005 Associate Professor of Biomedical Engineering, Johns Hopkins University 2005- Professor of Medicine, Johns Hopkins University 2005- Professor of Biomedical Engineering, Johns Hopkins University. Dr. Berger is rated as a Distinguished provider by MediFind in the treatment of Ventricular Fibrillation. His top areas of expertise are Atrial Fibrillation, Arrhythmias, Ventricular Tachycardia, Cardiac Ablation, and Pacemaker Implantation.

Roy Beinart is a Cardiologist in Baltimore, Maryland. Dr. Beinart is rated as a Distinguished provider by MediFind in the treatment of Ventricular Fibrillation. His top areas of expertise are Atrial Fibrillation, Ventricular Fibrillation, Ventricular Tachycardia, Pacemaker Implantation, and Cardiac Ablation.

Joseph Marine, MD, MBA, FACC, FHRS, is a clinical cardiac electrophysiologist who practices primarily at the Johns Hopkins Hospital in Baltimore, Maryland. He is a Professor of Medicine at the Johns Hopkins University School of Medicine and holds appointments as Vice-Director of Operations for the Division of Cardiology and Section Chief of Cardiology for Johns Hopkins Community Physicians. He trained at UC San Francisco Medical School, Brigham and Women’s Hospital/Harvard Medical School, Boston University Medical Center, and Beth Israel Deaconess Medical Center. Dr. Marine has lectured widely on a variety of arrhythmia topics and has served as a co-director of the American College of Cardiology (ACC) Cardiovascular Overview and Board Review Course for 10 years. He currently serves on the ACC Board of Governors and is co-editor of the ACC/HRS EP Self-Assessment Program. He also serves on other committees for the ACC, the Heart Rhythm Society, and MedChi. He is co-author of more than 130 original research and review articles and has served on writing committees for several national cardiology practice and training guidelines. As a clinical cardiac electrophysiologist, Dr. Marine specializes in the diagnosis and treatment of arrhythmias, which are heart rhythm disorders that cause the heart to beat too rapidly, too slowly, or irregularly. His research focuses on further improving the safety and effectiveness of catheter ablation and other treatments for atrial fibrillation and other atrial and ventricular arrhythmias. Dr. Marine is rated as an Advanced provider by MediFind in the treatment of Ventricular Fibrillation. His top areas of expertise are Atrial Fibrillation, Atrioventricular Nodal Reentrant Tachycardia (AVNRT), Arrhythmias, Cardiac Ablation, and Heart Transplant.

Dr. Richard (Rick) Carrick is a general cardiologist in the Johns Hopkins Division of Medicine and is an assistant professor of medicine at the Johns Hopkins School of Medicine. He also serves as associate director of the Johns Hopkins Hypertrophic Cardiomyopathy Center of Excellence. Originally from Massachusetts, he completed his medical training as well as a Ph.D. in Bioengineering at the University of Vermont and did his internal medicine residency training at Tufts Medical Center in Boston, MA. He completed his Cardiovascular Disease Fellowship and a T32 Research Fellowship at Johns Hopkins. His research focuses on the use of advanced computational techniques like machine-learning and artificial intelligence to improve risk stratification in patients with inherited heart disease. Clinically, he specializes in echocardiography and the care of patients with hypertrophic cardiomyopathy (HCM) and other genetic cardiomyopathies. Dr. Carrick is rated as an Advanced provider by MediFind in the treatment of Ventricular Fibrillation. His top areas of expertise are Cardiomyopathy, Hypertrophic Cardiomyopathy (HCM), Ventricular Tachycardia, Arrhythmias, and Cardiac Ablation.

Dr Halperin received the B.S degree in physics with highest distinction from Purdue University, the M.A. degree in physics from the University of California, Berkeley, and the M.D. degree from Louisiana State University, New Orleans, Louisiana. He is a member of Phi Beta Kappa, an Established Investigator and Fellow of the American Heart Association, and a McClure Fellow of the Johns Hopkins University Applied Physics laboratory. Dr. Halperin is currently a Professor of Medicine, Radiology and Biomedical Engineering at the Johns Hopkins Medical Institutions. He is the co-director of the Cardiovascular Imaging Center of Excellence. He serves on the editorial board of the journal Resuscitation, and is a past chair of the national American Heart Association Advanced Cardiovascular Life Support Subcommittee and a past member of the Emergency Cardiac Care Committee. Ten of his students have received young investigator awards from the American Heart Association and Heart Rhythm Society, and he has ongoing support from the National Institutes of Heath for his research programs. He has over 120 peer-reviewed publications and over 20 patents issued. Dr. Halperin is rated as a Distinguished provider by MediFind in the treatment of Ventricular Fibrillation. His top areas of expertise are Ventricular Fibrillation, Heart Attack, Ventricular Tachycardia, Cardiac Ablation, and Lithotripsy.

Dr. David Douglass Spragg is a Professor of Medicine in the Department of Medicine (Division of Cardiology) at Johns Hopkins. In addition, he is the inaugural Edward St. John Professor of Cardiology. His research focuses on treatments for atrial fibrillation (AF), and particularly on catheter ablation for AF. Dr. Spragg received his undergraduate degree in the Comparative Study of Religion from Harvard College. He earned his medical degree from the College of Physicians and Surgeons at Columbia University. After pursuing a Sarnoff Cardiovascular research fellowship at Brigham and Women's Hospital, Dr. Spragg completed his internship and residency at Massachusetts General Hospital. He came to Johns Hopkins in 2001 for Cardiology and Cardiac EP fellowships. He served as chief fellow for the Cardiology program, and was recognized for his research during fellowship as the Michel Mirowski Cardiology Fellow. Dr. Spragg joined the faculty as an Assistant Professor in 2006, and was promoted to Associate Professor in 2014. He was promoted to the rank of Professor of Medicine in 2024. Besides his teaching and clinical appointments at the Johns Hopkins School of Medicine, Dr. Spragg is the Director of the Johns Hopkins Atrial Fibrillation Research Program. He is a Fellow of the Heart Rhythm Society. Dr. Spragg is rated as an Advanced provider by MediFind in the treatment of Ventricular Fibrillation. His top areas of expertise are Atrial Fibrillation, Arrhythmias, Cardiac Tamponade, Cardiac Ablation, and Pacemaker Implantation.

"Originally from Wisconsin, Dr. Czarny attended the University of Wisconsin where he majored in molecular biology. After medical school at the Johns Hopkins University School of Medicine, he completed an internal medicine residency at the Brigham and Women’s Hospital in Boston followed by cardiovascular disease, interventional cardiology, and structural heart disease fellowships at Johns Hopkins. Currently, he is a faculty member in interventional cardiology and performs heart catheterizations and coronary artery stenting for patients with stable coronary artery disease (CAD) and myocardial infarctions (""heart attacks"") at both the Johns Hopkins Hospital and the Johns Hopkins Bayview Medical Center. He is also a member of the Structural Heart Disease team and performs minimally invasive, catheter-based treatments for structural heart disease at the Johns Hopkins Hospital including transcatheter aortic valve replacement (TAVR) for aortic valve stenosis, valve repair/replacement procedures for mitral valve regurgitation and stenosis, patent foramen ovale closure, atrial septal defect closure, alcohol septal ablation for hypertrophic cardiomyopathy, and left atrial appendage occlusion with the Watchman(TM) device. He sees patients in his structural heart disease clinics at both the Johns Hopkins Hospital and the Johns Hopkins Bayview Medical Center. Dr. Czarny's research interests include the safety of cardiac stenting at hospitals without cardiac surgery backup and outcomes of catheter-based structural heart procedures.". Dr. Czarny is rated as an Experienced provider by MediFind in the treatment of Ventricular Fibrillation. His top areas of expertise are Aortic Valve Stenosis, Apoplexy, Heart Attack, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Aronis is an Assistant Professor of Medicine in the Division of Cardiology at the Johns Hopkins School of Medicine, the Director of the Complex Adult Congenital Heart Disease Ablation Program, and the Associate Director of the Ventricular Tachycardia Ablation Program. He performs all types of electrophysiology procedures, with a special focus on complex catheter ablations for atrial and ventricular arrhythmias as well as complex ablations for arrhythmias in patients with adult congenital heart diseases. Dr. Aronis received his M.D. and Ph.D. degrees with Summa Cum Laude honors from the University of Patras School of Medicine in Greece. He completed his internal medicine residency training at Boston University Medical Center both his Cardiovascular Disease and Clinical Cardiac Electrophysiology fellowships at The Johns Hopkins Hospital. In addition, he has completed a post-doctoral research fellowship in Translational Research at Beth Israel Deaconess Medical Center / Harvard Medical School and an NIH funded (T-32) post-doctoral research fellowship in computational electrophysiology at the Institute of Computational Medicine at the Johns Hopkins Whiting School of Engineering. He actively engages in clinical trials and research studies aimed at improving patient outcomes and advancing the understanding of cardiac arrhythmias. He is a member of the American College of Cardiology, American Heart Association, and Heart Rhythm Society. Dr. Aronis is rated as an Experienced provider by MediFind in the treatment of Ventricular Fibrillation. His top areas of expertise are Atrial Fibrillation, Ventricular Tachycardia, Arrhythmias, Cardiac Ablation, and Pacemaker Implantation.

Charles Love is director of the Johns Hopkins Cardiac Rhythm Device Service. Dr. Love is one of the foremost international authorities on pacemaker and implantable cardioverter defibrillator implantation and management. He manages patients with all types of heart rhythm disorders and has particular interest in lead extraction and lead management strategies, with an emphasis on new tools to reduce complications and strategies to reduce infection. Dr. Love is rated as an Experienced provider by MediFind in the treatment of Ventricular Fibrillation. His top areas of expertise are Arrhythmias, Sick Sinus Syndrome, Ventricular Tachycardia, Pacemaker Implantation, and Cardiac Ablation.

Dr. Anum Minhas attended medical school at Duke University and trained in internal medicine at the University of Michigan, Ann Arbor. During her Cardiology fellowship training at Johns Hopkins University School of Medicine, she served as the Chief Cardiology fellow and was honored to receive the Marie-Josee and Henry R. Kravis Endowed Fellowship and the Lou and Nancy Grasmick Endowed Research Fellowship (2021-2022). She was also awarded the Dlabal Clinical Research award for originality and creativity in research. During her fellowship, she completed additional training and obtained a Master of Health Science with focus in cardiovascular epidemiology as an NIH T32 postdoctoral fellow at the Johns Hopkins Bloomberg School of Public Health. She also completed additional clinical training during fellowship in Advanced Echocardiography, and designed and completed an inaugural fellowship in Cardio-Obstetrics. Dr. Minhas joined the Johns Hopkins Cardiology faculty with a clinical focus in women's cardiovascular health, specifically Cardio-Obstetrics, or cardiac disease around pregnancy. She also attends in the coronary critical care unit and the echocardiography laboratory. She was selected as a recipient of an NIH-sponsored KL2 award through the Clinical Research Scholars Program. Her current research focuses on preventing and managing cardiovascular disease associated with pregnancy complications, such as preeclampsia. She is the recipient of several grants and has coauthored multiple publications and book chapters in women's cardiovascular health. She hopes to use her research to raise awareness of and provide insights into mechanisms of pregnancy-associated cardiac disease and promote health equity in maternal health. Videos Community ConversationMaternal Health Recent News Articles and Media Coverage https://the1a.org/segments/in-good-health-unpacking-heart-disease-in-women/ In Good Health: Medical missteps for women with heart disease, NPR Podcast. Dr. Minhas is rated as an Experienced provider by MediFind in the treatment of Ventricular Fibrillation. Her top areas of expertise are Peripartum Cardiomyopathy, Pulmonary Edema, COVID-19, and Cardiomyopathy.

Dr. Cingolani is an Associate Professor at The Johns Hopkins University School of Medicine, Division of Cardiology. He earned his medical degree from Universidad Nacional de La Plata, Argentina, and completed his Internship and Internal Medicine Residency at CEMIC, Buenos Aires, Argentina, and hypertension research post-doctoral fellowship at Henry Ford Hospital, Detroit, MI. After completing his Internal Medicine Residency at The Reading Hospital and Medical Center in Pennsylvania, Dr. Cingolani joined The Johns Hopkins Hospital as a Cardiology fellow, where he remained in the Faculty after his training. Currently, he is the Associate Director of The Johns Hopkins Hospital Coronary Care Unit, Director of the Hypertension Center and member of the Echocardiography Lab and Outpatient Cardiology Clinic. He also teaches pathophysiology to medical students. Dr. Cingolani’s research interests focus on hypertensive heart disease and its transition to heart failure. He aims to elucidate the mechanism/s by which certain matricellular proteins present in the heart seem to play a protective role. His research is mainly supported by the National Institute of Health (NIH). He is also the principal investigator of the DREAM study group, studying the effect of Melatonin in preventing atrial fibrillation in patients undergoing cardiac surgery. Dr. Cingolani has been recognized by the Council for High Blood Pressure Research of the American Heart Association for his work in hypertension and is the 2011 recipient of the PJ Schafer Memorial Heart Research Award, the 2012 Michel Mirowski Discovery Fund Award, and 2013 Magic that matters Fund. Dr. Cingolani is rated as an Experienced provider by MediFind in the treatment of Ventricular Fibrillation. His top areas of expertise are Paroxysmal Supraventricular Tachycardia (PSVT), Multifocal Atrial Tachycardia, Atrioventricular Nodal Reentrant Tachycardia (AVNRT), Cardiac Ablation, and Tissue Biopsy.

Magdi Saba is a Cardiologist in Baltimore,, Maryland. Dr. Saba is rated as an Advanced provider by MediFind in the treatment of Ventricular Fibrillation. His top areas of expertise are Ventricular Tachycardia, Arrhythmias, Ventricular Fibrillation, Paroxysmal Supraventricular Tachycardia (PSVT), and Cardiac Ablation.

Dr. Robert Weiss is a Clarence Doodeman professor of cardiology as well as a professor of medicine and radiology at the Johns Hopkins University School of Medicine. Dr. Weiss directs a multi-disciplinary team at Johns Hopkins as well as collaborators at Cedars Sinai Medical Center in Los Angeles are dedicated to identifying the most important clinical, genetic, structural, contractile and metabolic causes of sudden cardiac death as well as the means to reverse the underlying pathology and lower risk. His research interests include energetic consequences and causes of heart failure, predictors of sudden cardiac death, non-invasive magnetic resonance, role of creatine kinase in heart failure, spectroscopy and imaging, coronary endothelial function and small animal cardiovascular imaging. Dr. Weiss received an undergraduate degree in physics form Dickinson College and a medical degree from Pennsylvania State University College of Medicine AOA Hershey Medical Center before joining Johns Hopkins in 1983 as an intern and assistant resident. Dr. Weiss has published extensively and has most recently been awarded a fellowship with the International Society of Magnetic Resonance in Medicine. Dr. Weiss is rated as an Experienced provider by MediFind in the treatment of Ventricular Fibrillation. His top areas of expertise are Pulmonary Hypertension, Heart Attack, Pulmonary Veno-Occlusive Disease, and Coronary Heart Disease.

Roy Sumon is a Cardiologist in Baltimore,, Maryland. Dr. Sumon has been practicing medicine for over 10 years and is rated as an Advanced provider by MediFind in the treatment of Ventricular Fibrillation. His top areas of expertise are Ventricular Fibrillation, Heart Attack, Coronary Heart Disease, Percutaneous Coronary Intervention (PCI), and Stent Placement.

Dr. Joao Lima is a professor of medicine, radiology and epidemiology at the Johns Hopkins School of Medicine. His pioneering work in cardiac imaging using advanced MRI, CT and echocardiography has led to noninvasive techniques for predicting cardiovascular disease and calculating its extent, as well as measuring the effectiveness of modern cardiac treatments. He holds numerous patents on devices and methods for cardiac imaging and image-guided therapies. Dr. Lima graduated medical school at the University of Bahia, Brazil. He completed his cardiology fellowship at Johns Hopkins and spent two years on the faculty of the University of Pennsylvania before returning to Hopkins as a faculty member in 1992. A long-time investigator with the Multi-Ethnic Study of Atherosclerosis (MESA), Dr. Lima is credited with more than 175 articles out of that study and nearly 575 publications over his career. He is associate editor of Journal of the American College of Cardiology and serves on the editorial board of the Italian Journal of Cardiology while reviewing for other journals including the New England Journal of Medicine, Circulation and Annals of Internal Medicine. Dr. Lima has been invited to present his research throughout the Americas, Europe and Asia. Dr. Lima is rated as an Experienced provider by MediFind in the treatment of Ventricular Fibrillation. His top areas of expertise are Atherosclerosis, Heart Attack, Apoplexy, Arterial Embolism, and Bone Marrow Aspiration.

James Weiss is a Cardiologist in Baltimore, Maryland. Dr. Weiss is rated as a Distinguished provider by MediFind in the treatment of Ventricular Fibrillation. His top areas of expertise are Ventricular Fibrillation, Low Potassium Level, Heart Attack, Arrhythmias, and Cardiac Ablation.

Julia Cadrin is a Cardiologist in Baltimore,, Maryland. Dr. Cadrin is rated as an Advanced provider by MediFind in the treatment of Ventricular Fibrillation. Her top areas of expertise are Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy, Cardiac Arrest, Familial Hypertrophic Cardiomyopathy, and Cardiac Ablation.

Alan Cheng is a Cardiologist in Baltimore,, Maryland. Dr. Cheng is rated as an Advanced provider by MediFind in the treatment of Ventricular Fibrillation. His top areas of expertise are Ventricular Fibrillation, Arrhythmias, Ventricular Tachycardia, Cardiac Tamponade, and Cardiac Ablation.

Dr. Jeffrey C. Trost is an associate professor of medicine at the Johns Hopkins School of Medicine as well as director of the Cardiac Catheterization Laboratory at Johns Hopkins Bayview Medical Center. His research there focuses on cardiac disease and cardiovascular medicine. He is also currently deputy director of clinical activities at Johns Hopkins Bayview Medical Center. Dr. Trost earned his undergraduate degree at Princeton University and medical degree at the University of Pennsylvania School of Medicine. He completed a residency at the University of Texas Southwestern School of Medicine where he was chief resident from 1999-2000. He was an assistant professor of internal medicine at the University of Texas Southwestern School of Medicine and an interventional cardiovascular fellow at Brown University before joining the Johns Hopkins faculty in 2005. Dr. Trost was most recently recognized with the 2016 Hopkins Medicine Clinical Recognition Award for Quality and Safety and the 2016 Hopkins Cardiology Fellows’ Teaching Award. Dr. Trost is rated as an Experienced provider by MediFind in the treatment of Ventricular Fibrillation. His top areas of expertise are Heart Attack, Apoplexy, Arterial Embolism, Coronary Artery Bypass Graft (CABG), and Heart Bypass Surgery.

Dr. Marlene Stephanie Williams is an Associate professor at the Johns Hopkins University School of Medicine. Her research focuses on coronary atherosclerosis and platelet function, and her particular focus is on platelet function as it relates to the acute coronary syndrome. Dr. Williams has examined platelet function and its correlation to platelet functional genomics and runs a platelet physiology laboratory on the Johns Hopkins Bayview campus. The goal for her cardiovascular platelet laboratory has been to identify the etiology of platelet dysfunction in many disease states and apply methods that may improve this dysfunction that may eventually be translated to therapies for patients with cardiovascular disease. She is a prior recipient of an NIH career mentored award (K23) examining platelet functional genomics and an NIH RO1 award addressing platelet serotonin signaling in depression and heart disease. Dr. Williams has several publications covering platelet functional changes in settings of interventional cardiology, acute coronary syndrome, and heart disease and depression. She has participated in several NHLBI advisory committees, review groups, and study sections. Dr. Williams has been the Course Director, of the advanced clinical clerkship in coronary intensive care at the Bayview Medical center and has mentored many medical residents and cardiology fellows. Dr. Williams received her undergraduate degree in biochemistry from McGill University. She earned a medical degree from the Columbia University College of Physicians & Surgeons and completed a residency at Johns Hopkins Hospital. After completing a residency, Dr. Williams was a cardiology fellow at Mount Sinai Hospital and Johns Hopkins Hospital. Dr. Williams is currently the Clinical Director of Cardiology at Johns Hopkins Bayview Medical Center. Dr. Williams is rated as an Experienced provider by MediFind in the treatment of Ventricular Fibrillation. Her top areas of expertise are Heart Attack, Apoplexy, Arterial Embolism, Pacemaker Implantation, and Hip Replacement.